about
Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function.Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward.Tissue Doppler-derived E/e' ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease.Pathogenesis and therapeutic implications of cardiorenal syndrome.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Nebivolol for the treatment of heart failure.Urine biochemistry assessment in critically ill patients: controversies and future perspectives.New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations.Urinary NGAL and hematic ADMA levels: an early sign of cardio-renal syndrome in young adults born preterm?Molecular models of the cardiorenal syndrome.Risk of nephrotoxicity among patients who received vancomycin.The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study.Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.Decreased vancomycin clearance in patients with congestive heart failure.
P2860
Q33769695-A6ED3478-E321-4010-B489-33BDCE25B210Q35622822-F364DC65-0900-45D4-A7DE-397CD826D4B4Q36528904-B008D6B8-BBA7-4A9C-BAF7-C04E655BE85AQ37812022-26F0E065-9D67-4DD6-AD60-5CCD5A9AA7FAQ37891878-21AB2B9B-4831-4FAD-8CCE-7E67F7AB0D0EQ37943377-A574EBB0-2FD2-4D31-9208-BA33C04537AFQ38796280-3D1420EA-2A86-4260-A91E-7B82188C4041Q39218629-6381BDC1-A80F-44C1-BD07-63794FE74C6AQ39344760-5B5D9F92-D885-4A58-94DB-05D9C7559C83Q46899838-07888351-5C5A-4972-BD71-BBFAE44F7EA7Q47795209-56151733-AEE9-4FA5-A012-0521E2C3F803Q48172048-90338748-E98B-49A5-8113-71D04DC8AD25Q48680598-D618EC3E-6303-4776-A9CD-69BC7DB2B78EQ50788583-821E4526-84EE-42B2-B344-67276CAF3DC3Q51344353-E7153F2A-2C90-4E71-995D-AC20D33DF9A6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiorenal syndrome: still not a defined entity.
@en
Cardiorenal syndrome: still not a defined entity.
@nl
type
label
Cardiorenal syndrome: still not a defined entity.
@en
Cardiorenal syndrome: still not a defined entity.
@nl
prefLabel
Cardiorenal syndrome: still not a defined entity.
@en
Cardiorenal syndrome: still not a defined entity.
@nl
P2860
P1476
Cardiorenal syndrome: still not a defined entity.
@en
P2093
Carlo Longhini
Christian Molino
P2860
P2888
P356
10.1007/S10157-009-0257-4
P577
2010-02-20T00:00:00Z